Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990-2015

Глобальное бремя артериальной гипертензии и систолического артериального давления не менее 110–115 мм рт. ст., 1990–2015 гг.
Amitava Banerjee, Christopher J L Murray, Tomi Akinyemiju, Till Bärnighausen, Kara Estep, Valery L. Feigin, Florian Fischer, Graeme J. Hankey, Jost Bruno Jonas, Yun Jin Kim, Ruth W Kimokoti, Paulo A. Lotufo, Ali H. Mokdad, Farshad Pourmalek, Gregory A. Roth, Itamar S Santos, Aletta Elisabeth Schutte, Sadaf Ghajarieh Sepanlou, Marcello A. Tonelli, Tommi Juhani Vasankari, Narayanaswamy Venketasubramanian, Vasily Vlassov, Theo Vos, Ronny Westerman, Yuichiro Yano, Naohiro Yonemoto, Suzanne E. Judd, Kalkidan Hassen Abate, Sibhatu Biadgilign, Stan Biryukov, Maysaa El Sayed Zaki, João Carlos Fernandes, Mohammad Hossein Forouzanfar, Young‐Ho Khang, Yoshihiro Kokubo, Yohannes Adama Melaku, Rajesh Kumar, Amanda Gay Thrift, Kingsley Nnanna Ukwaja, Olalekan Abdulrahman Uthman, Rajeev Gupta, Marie Ng, Raghib Ali, Nelson Alvis‐Guzmán, Derrick Bennett, George A. Mensah, Takayoshi Ohkubo, Uchechukwu K.A. Sampson, Ivy Shiue, Alan D López, Bruce Charles Neal, Andrew Moran, Laurie B. Marczak, Lily Alexander, Peter S. Azzopardi, Arindam Basu, Ferrán Catalá-López, Philimon Nyakauru Gona, Dhaval Sanjeev Kolte, Frida Namnyak Ngalesoni, Anwar Rafay, David Rojas‐Rueda, Monika S. Sawhney, Bemnet Tedla, Thomas Truelsen, Lijing L. Yan, Alemseged Aregay Gebru, Ardeshir Khosravi, Patrick Liu, Tolesa Bekele, Awoke Misganaw, Nikolaos Tsilimparis, Girma Temam Shifa, Haseeb Nawaz, Reza Malekzadeh
2017-01-10

comparative risk assessmentdisability-adjusted life yearsglobal burden of diseasespatiotemporal Gaussian process regressionsystolic blood pressure
Importance: Elevated systolic blood (SBP) pressure is a leading global health risk. Quantifying the levels of SBP is important to guide prevention policies and interventions. Objective: To estimate the association between SBP of at least 110 to 115 mm Hg and SBP of 140 mm Hg or higher and the burden of different causes of death and disability by age and sex for 195 countries and territories, 1990-2015. Design: A comparative risk assessment of health loss related to SBP. Estimated distribution of SBP was based on 844 studies from 154 countries (published 1980-2015) of 8.69 million participants. Spatiotemporal Gaussian process regression was used to generate estimates of mean SBP and adjusted variance for each age, sex, country, and year. Diseases with sufficient evidence for a causal relationship with high SBP (eg, ischemic heart disease, ischemic stroke, and hemorrhagic stroke) were included in the primary analysis. Main Outcomes and Measures: Mean SBP level, cause-specific deaths, and health burden related to SBP (≥110-115 mm Hg and also ≥140 mm Hg) by age, sex, country, and year. Results: Between 1990-2015, the rate of SBP of at least 110 to 115 mm Hg increased from 73 119 (95% uncertainty interval [UI], 67 949-78 241) to 81 373 (95% UI, 76 814-85 770) per 100 000, and SBP of 140 mm Hg or higher increased from 17 307 (95% UI, 17 117-17 492) to 20 526 (95% UI, 20 283-20 746) per 100 000. The estimated annual death rate per 100 000 associated with SBP of at least 110 to 115 mm Hg increased from 135.6 (95% UI, 122.4-148.1) to 145.2 (95% UI 130.3-159.9) and the rate for SBP of 140 mm Hg or higher increased from 97.9 (95% UI, 87.5-108.1) to 106.3 (95% UI, 94.6-118.1). For loss of DALYs associated with systolic blood pressure of 140 mm Hg or higher, the loss increased from 95.9 million (95% uncertainty interval [UI], 87.0-104.9 million) to 143.0 million (95% UI, 130.2-157.0 million) [corrected], and for SBP of 140 mm Hg or higher, the loss increased from 5.2 million (95% UI, 4.6-5.7 million) to 7.8 million (95% UI, 7.0-8.7 million). The largest numbers of SBP-related deaths were caused by ischemic heart disease (4.9 million [95% UI, 4.0-5.7 million]; 54.5%), hemorrhagic stroke (2.0 million [95% UI, 1.6-2.3 million]; 58.3%), and ischemic stroke (1.5 million [95% UI, 1.2-1.8 million]; 50.0%). In 2015, China, India, Russia, Indonesia, and the United States accounted for more than half of the global DALYs related to SBP of at least 110 to 115 mm Hg. Conclusions and Relevance: In international surveys, although there is uncertainty in some estimates, the rate of elevated SBP (≥110-115 and ≥140 mm Hg) increased substantially between 1990 and 2015, and DALYs and deaths associated with elevated SBP also increased. Projections based on this sample suggest that in 2015, an estimated 3.5 billion adults had SBP of at least 110 to 115 mm Hg and 874 million adults had SBP of 140 mm Hg or higher.
1
Annual deaths associated with SBP at least 110–115 mm Hg increased from 135.6 to 145.2 per 100,000, while deaths associated with SBP at least 140 mm Hg increased from 97.9 to 106.3 per 100,000.
2
DALYs associated with SBP at least 140 mm Hg increased from 95.9 million to 143.0 million between 1990 and 2015, indicating a growing global health burden.
3
The global prevalence of SBP at least 110–115 mm Hg increased from 73,119 to 81,373 per 100,000 between 1990 and 2015.
4
The global prevalence of SBP at least 140 mm Hg increased from 17,307 to 20,526 per 100,000 over the same period.
5
Using 844 studies involving 8.69 million participants, the analysis estimated systolic blood pressure distributions and attributable health burdens across 195 countries and territories from 1990 to 2015.

Global populations across 195 countries and territories, characterized by systolic blood pressure (SBP) levels from 1990 to 2015

Age-, sex-, country-, and year-specific associations of SBP thresholds (≥110–115 mm Hg and ≥140 mm Hg) with cause-specific mortality and disability burden

Publication Details
Publication Date
2017-01-10
Journal
Publisher
ISSN
Access Type
Author Information
Authors
Amitava Banerjee
Christopher J L Murray
Tomi Akinyemiju
Till Bärnighausen
Kara Estep
Valery L. Feigin
Florian Fischer
Graeme J. Hankey
Jost Bruno Jonas
Yun Jin Kim
Ruth W Kimokoti
Paulo A. Lotufo
Ali H. Mokdad
Farshad Pourmalek
Gregory A. Roth
Itamar S Santos
Aletta Elisabeth Schutte
Sadaf Ghajarieh Sepanlou
Marcello A. Tonelli
Tommi Juhani Vasankari
Narayanaswamy Venketasubramanian
Vasily Vlassov
Theo Vos
Ronny Westerman
Yuichiro Yano
Naohiro Yonemoto
Suzanne E. Judd
Kalkidan Hassen Abate
Sibhatu Biadgilign
Stan Biryukov
Maysaa El Sayed Zaki
João Carlos Fernandes
Mohammad Hossein Forouzanfar
Young‐Ho Khang
Yoshihiro Kokubo
Yohannes Adama Melaku
Rajesh Kumar
Amanda Gay Thrift
Kingsley Nnanna Ukwaja
Olalekan Abdulrahman Uthman
Rajeev Gupta
Marie Ng
Raghib Ali
Nelson Alvis‐Guzmán
Derrick Bennett
George A. Mensah
Takayoshi Ohkubo
Uchechukwu K.A. Sampson
Ivy Shiue
Alan D López
Bruce Charles Neal
Andrew Moran
Laurie B. Marczak
Lily Alexander
Peter S. Azzopardi
Arindam Basu
Ferrán Catalá-López
Philimon Nyakauru Gona
Dhaval Sanjeev Kolte
Frida Namnyak Ngalesoni
Anwar Rafay
David Rojas‐Rueda
Monika S. Sawhney
Bemnet Tedla
Thomas Truelsen
Lijing L. Yan
Alemseged Aregay Gebru
Ardeshir Khosravi
Patrick Liu
Tolesa Bekele
Awoke Misganaw
Nikolaos Tsilimparis
Girma Temam Shifa
Haseeb Nawaz
Reza Malekzadeh
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%